Pillar[6]arene acts as a biosensor for quantitative detection of a vitamin metabolite in crude biological samples.
Masaya UenoTakuya TomitaHiroshi ArakawaTakahiro KakutaTada-Aki YamagishiJumpei TerakawaTakiko DaikokuShin-Ichi HorikeSha SiKenta KurayoshiChiaki ItoAtsuko KasaharaYuko TadokoroMasahiko KobayashiTsutomu FukuwatariIkumi TamaiAtsushi HiraoTomoki OgoshiPublished in: Communications chemistry (2020)
Metabolic syndrome is associated with obesity, hypertension, and dyslipidemia, and increased cardiovascular risk. Therefore, quick and accurate measurements of specific metabolites are critical for diagnosis; however, detection methods are limited. Here we describe the synthesis of pillar[n]arenes to target 1-methylnicotinamide (1-MNA), which is one metabolite of vitamin B3 (nicotinamide) produced by the cancer-associated nicotinamide N-methyltransferase (NNMT). We found that water-soluble pillar[5]arene (P5A) forms host-guest complexes with both 1-MNA and nicotinamide, and water-soluble pillar[6]arene (P6A) selectively binds to 1-MNA at the micromolar level. P6A can be used as a "turn-off sensor" by photoinduced electron transfer (detection limit is 4.38 × 10 -6 M). In our cell-free reaction, P6A is used to quantitatively monitor the activity of NNMT. Moreover, studies using NNMT-deficient mice reveal that P6A exclusively binds to 1-MNA in crude urinary samples. Our findings demonstrate that P6A can be used as a biosensor to quantify 1-MNA in crude biological samples.
Keyphrases
- water soluble
- label free
- electron transfer
- metabolic syndrome
- cell free
- loop mediated isothermal amplification
- sensitive detection
- real time pcr
- insulin resistance
- gold nanoparticles
- blood pressure
- high resolution
- type diabetes
- quantum dots
- genome wide
- physical activity
- gene expression
- single cell
- cardiovascular disease
- uric acid
- weight gain
- cardiovascular risk factors
- case control